Frederick Barrett MD
Instructor of Psychiatry and Behavioral Sciences
Join to View Full Profile
1910 Nonconnah BlvdSuite 120Memphis, TN 38132
Phone+1 901-448-2300
Fax+1 901-448-6657
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frederick Barrett, MD is a pediatric infectious disease specialist in Memphis, Tennessee.
Education & Training
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2013 - 2015
Boston Children’s Hospital/Boston Medical Center AFellowship, Pediatric Infectious Diseases, 1966 - 1968
Baylor College of Medicine (Houston)Residency, Pediatrics, 1964 - 1965- Baylor College of MedicineClass of 1961
Certifications & Licensure
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 61 citationsDouble-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognitionFrederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz, Matthew W. Johnson, Roland R. Griffiths
Psychopharmacology. 2018-07-30 - 59 citationsAn outbreak of aspergillosis in children with acute leukemiaDonald H. Mahoney, C. Philip Steuber, Kenneth A. Starling, Fred F. Barrett, Jacobo Goldberg
The Journal of Pediatrics. 1979-07-01 - 27 citationsA fatal x-linked recessive reticuloendothelial syndrome with hyperglobulinemia. X-linked recessive reticuloendotheliosis.John M. Falletta, Donald J. Fernbach, Don B. Singer, Mary Ann South, Benjamin H. Landing
The Journal of Pediatrics. 1973-10-01
Press Mentions
- How Psilocybin, the Psychedelic in Mushrooms, May Rewire the Brain to Ease Depression, Anxiety and MoreJune 11th, 2022
- PharmaDrug Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- PharmaDrug Announces Clinical Research Collaboration with the Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- Join now to see all
